Product Information
IBUPROFEN 400 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0391 per EA under NDC 64380080907. Its NADAC has been published 416 times since Sep 5, 2018.
FDA first approved this application on Feb 5, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380080907
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA078329FDA Approved
2/5/2009
TE Code
AB
On Market Since
8/24/2018
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 400 MG TABLET has been published 416 times since Sep 5, 2018, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0391 per EA |
|---|---|
| All-time high | $0.0577 (Sep 15, 2021) |
| All-time low | $0.0336 (Sep 19, 2018) |
| 52-week high | $0.0433 |
| 52-week low | $0.0387 |
| Median price | $0.0472 |
| Average price | $0.0468 |
| Largest weekly change | -25.2% (Nov 20, 2024) |
| Weeks tracked | 416 |
| Tracking since | Sep 5, 2018 |
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IBUPROFEN 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 400 MG TABLET, manufactured by Strides Pharma Inc., is $0.0391 per EA (NDC 64380080907), effective Aug 19, 2026.
How has the price of IBUPROFEN 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 400 MG TABLET has held within roughly two percent of its current level. It has been tracked across 416 weekly CMS publications since Sep 5, 2018.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 400 MG TABLET?
Since Sep 5, 2018, the NADAC for IBUPROFEN 400 MG TABLET has ranged from a low of $0.0336 (Sep 19, 2018) to a high of $0.0577 (Sep 15, 2021), with a median of $0.0472 per EA.
Are there cheaper alternatives to IBUPROFEN 400 MG TABLET?
14 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IBUPROFEN 400 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures IBUPROFEN 400 MG TABLET?
IBUPROFEN 400 MG TABLET (NDC 64380080907) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.